Literature DB >> 19940835

Acute HIV infection - New York City, 2008.

.   

Abstract

Acute human immunodeficiency virus (HIV) infection (AHI) is a highly infectious phase of disease that lasts approximately 2 months and is characterized by nonspecific clinical symptoms. AHI contributes disproportionately to HIV transmission because it is associated with a high level of viremia, despite negative or indeterminate antibody (Ab) tests. Diagnosis of AHI with individual or pooled nucleic acid amplification tests (p-NAAT) can enable infected persons to adopt behaviors that reduce HIV transmission, facilitate partner referral for counseling and testing, and identify social networks of persons with elevated rates of HIV transmission. The national HIV surveillance case definition does not distinguish AHI from other stages of HIV infection, and the frequency of AHI among reported HIV cases is unknown. In 2008, to increase detection of AHI and demonstrate the feasibility of AHI surveillance, the New York City Department of Health and Mental Hygiene (NYC DOHMH) initiated p-NAAT screening at four sexually transmitted disease (STD) clinics and enhanced citywide HIV surveillance (using a standard case definition) to differentiate AHI among newly reported cases. Seventy cases of AHI (representing 1.9% of all 3,635 HIV diagnoses reported in New York City) were identified: 53 cases from enhanced surveillance and 17 cases from p-NAAT screening (representing 9% of 198 HIV diagnoses at the four clinics). Men who have sex with men (MSM) constituted 81% of AHI cases. Screening STD clinic patients, especially MSM, with p-NAAT can identify additional cases of HIV infection. Surveillance for AHI is feasible and can identify circumstances in which HIV prevention efforts should be intensified.

Entities:  

Mesh:

Year:  2009        PMID: 19940835

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  12 in total

1.  Integrating acute HIV infection within routine public health surveillance practices in New York City.

Authors:  Sara Bodach; Sarah Braunstein; Marie Antoinette Bernard; Charulata Jain Sabharwal; Adey Tsega; Colin Shepard
Journal:  Public Health Rep       Date:  2012 Jul-Aug       Impact factor: 2.792

Review 2.  HIV diagnostic testing: evolving technology and testing strategies.

Authors:  Demetre Daskalakis
Journal:  Top Antivir Med       Date:  2011 Feb-Mar

3.  HIV testing updates and challenges: when regulatory caution and public health imperatives collide.

Authors:  Bernard M Branson
Journal:  Curr HIV/AIDS Rep       Date:  2015-03       Impact factor: 5.071

Review 4.  Global epidemiology of HIV infection in men who have sex with men.

Authors:  Chris Beyrer; Stefan D Baral; Frits van Griensven; Steven M Goodreau; Suwat Chariyalertsak; Andrea L Wirtz; Ron Brookmeyer
Journal:  Lancet       Date:  2012-07-20       Impact factor: 79.321

Review 5.  Role of acute and early HIV infection in the sexual transmission of HIV.

Authors:  William C Miller; Nora E Rosenberg; Sarah E Rutstein; Kimberly A Powers
Journal:  Curr Opin HIV AIDS       Date:  2010-07       Impact factor: 4.283

6.  Evaluation of HIV incidence surveillance in New York City, 2006.

Authors:  Hemanth P Nair; Lucia V Torian; Lisa Forgione; Elizabeth M Begier
Journal:  Public Health Rep       Date:  2011 Jan-Feb       Impact factor: 2.792

7.  Ten Years of Screening and Testing for Acute HIV Infection in North Carolina.

Authors:  JoAnn D Kuruc; Anna B Cope; Lynne A Sampson; Cynthia L Gay; Rhonda M Ashby; Evelyn M Foust; Myra Brinson; John E Barnhart; David Margolis; William C Miller; Peter A Leone; Joseph J Eron
Journal:  J Acquir Immune Defic Syndr       Date:  2016-01-01       Impact factor: 3.731

8.  Performance of a fourth-generation HIV screening assay and an alternative HIV diagnostic testing algorithm.

Authors:  Muazzam Nasrullah; Laura G Wesolowski; William A Meyer; S Michele Owen; Silvina Masciotra; Craig Vorwald; William J Becker; Bernard M Branson
Journal:  AIDS       Date:  2013-03-13       Impact factor: 4.177

9.  Cost-effectiveness of pooled nucleic acid amplification testing for acute HIV infection after third-generation HIV antibody screening and rapid testing in the United States: a comparison of three public health settings.

Authors:  Angela B Hutchinson; Pragna Patel; Stephanie L Sansom; Paul G Farnham; Timothy J Sullivan; Berry Bennett; Peter R Kerndt; Robert K Bolan; James D Heffelfinger; Vimalanand S Prabhu; Bernard M Branson
Journal:  PLoS Med       Date:  2010-09-28       Impact factor: 11.069

10.  Sentinel surveillance of HIV-1 transmitted drug resistance, acute infection and recent infection.

Authors:  Hong-Ha M Truong; Timothy A Kellogg; Willi McFarland; Brian Louie; Jeffrey D Klausner; Susan S Philip; Robert M Grant
Journal:  PLoS One       Date:  2011-10-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.